Cargando…

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis

Detalles Bibliográficos
Autores principales:	Hayward, Kelly L., Bansal, Vikas, Valery, Patricia C., Irvine, Katharine M., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., Cottrell, W. Neil, Martin, Jennifer H., Powell, Elizabeth E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592784/ https://www.ncbi.nlm.nih.gov/pubmed/35560798 http://dx.doi.org/10.1002/hep4.1999

Ejemplares similares

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2020)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Reply
por: Hayward, Kelly L., et al.
Publicado: (2019)

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
por: Hayward, Kelly L., et al.
Publicado: (2016)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

Curative effect of hepatic portal venous administration of autologous bone marrow in AIDS patients with decompensated liver cirrhosis
por: Liu, B, et al.
Publicado: (2013)

Urgent Liver Transplantation Soon After Recovery From COVID‐19 in a Patient With Decompensated Liver Cirrhosis
por: Martini, Silvia, et al.
Publicado: (2020)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report
por: Mora-Peris, Borja, et al.
Publicado: (2015)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Kidney Tubular Injury Biomarkers and Secretory Function in Acute Decompensated Heart Failure
por: Kula, Alexander J., et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
por: Johnson, Amy L, et al.
Publicado: (2021)

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
por: Valery, Patricia C., et al.
Publicado: (2022)

Infantile Cirrhosis of the Liver
por: Iyer, L. R. Narayana
Publicado: (1927)

An idea whose time has come
por: Banci, Lucia, et al.
Publicado: (2007)

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Spontaneous cryptococcal peritonitis with fungemia in patients with decompensated cirrhosis: Report of two cases
por: Bal, Chinmaya Kumar, et al.
Publicado: (2014)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Corrigendum: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bl4rueq6t746p0043sb1mg3fb